Literature DB >> 11787528

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches.

T M Friedman1, G Varadi, D D Hopely, J Filicko, J Wagner, A Ferber, J Martinez, J Brunner, D Grosso, L McGuire, R Korngold, N Flomenberg.   

Abstract

Nonmyeloablative pretransplantation conditioning regimens have resulted in durable engraftment of allogeneic hematopoietic stem cells. In contrast to conventional fully myeloablative approaches, nonmyeloablative regimens are associated with a marked reduction of morbidity and mortality in the early posttransplantation period. Consequently, such reduced-intensity transplantation approaches can be used in older and frailer patients who would not tolerate fully ablative regimens. However, it is currently unclear how this radically different transplantation strategy affects immunological reconstitution. To address this important issue, we used T-cell receptor Vbeta spectratype analysis to examine the distribution of complementarity-determining region 3 (CDR3)-size bands as a measure of the complexity of the redeveloping T-cell repertoire. For this study, we evaluated the T-cell repertoire of 9 patients receiving T-cell replete, matched unrelated donor transplants following fully ablative or nonmyeloablative conditioning regimens. All 4 of the myeloablative and 2 of the nonmyeloablative patients received bone marrow, whereas 3 other nonmyeloablative patients received peripheral blood stem cells. The results of the spectratype analysis demonstrated that the patients who received nonmyeloablative conditioning together with either bone marrow or peripheral blood stem cells exhibited more rapid reconstitution of T-cell repertoire complexity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11787528     DOI: 10.1053/bbmt.2001.v7.pm11787528

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  8 in total

Review 1.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Authors:  Hiroto Inaba; Christine M Hartford; Deqing Pei; Meredith J Posner; Jie Yang; Randall T Hayden; Ashok Srinivasan; Brandon M Triplett; Jon A McCulllers; Ching-Hon Pui; Wing Leung
Journal:  Br J Haematol       Date:  2011-10-24       Impact factor: 6.998

3.  Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

Authors:  Sarfraz A Memon; Claude Sportès; Francis A Flomerfelt; Ronald E Gress; Frances T Hakim
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

4.  T cell repertoire complexity is conserved after LLME treatment of donor lymphocyte infusions.

Authors:  Thea M Friedman; Joanne Filicko-O'Hara; Bijoyesh Mookerjee; John L Wagner; Delores A Grosso; Neal Flomenberg; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2007-12       Impact factor: 5.742

5.  Single cell analysis of complex thymus stromal cell populations: rapid thymic epithelia preparation characterizes radiation injury.

Authors:  Kirsten M Williams; Heather Mella; Philip J Lucas; Joy A Williams; William Telford; Ronald E Gress
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

6.  Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation.

Authors:  Thea M Friedman; Kira Goldgirsh; Stephanie A Berger; Jenny Zilberberg; Joanne Filicko-O'Hara; Neal Flomenberg; Michele Donato; Scott D Rowley; Robert Korngold
Journal:  Blood       Date:  2008-06-09       Impact factor: 22.113

Review 7.  Immune deficits in allogeneic hematopoietic stem cell transplant (HSCT) recipients.

Authors:  Muhammad A Mir; Minoo Battiwalla
Journal:  Mycopathologia       Date:  2009-01-21       Impact factor: 2.574

8.  Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease.

Authors:  Joanne Filicko-O'Hara; Dolores Grosso; Phyllis R Flomenberg; Thea M Friedman; Janet Brunner; William Drobyski; Andres Ferber; Irina Kakhniashvili; Carolyn Keever-Taylor; Bijoyesh Mookerjee; Julie-An Talano; John I Wagner; Robert Korngold; Neal Flomenberg
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-08       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.